Medication and falls risk in the Older Person
![Polypharmacy icon of two pills](/media/1264/polypharmacy-icon.png)
Reproduced from BHPS at this link
This classification has been based upon a review of the clinical evidence of medicines most commonly implicated in falls.22 The list is not meant to be fully comprehensive but intended to raise awareness. Advice is provided on how medicines should be stopped (deprescribed).
Highest risk |
Guidance |
Antidepressants |
Avoid tricyclic antidepressants especially with high anti-muscarinic activity e.g. amitriptyline. SSRIs are associated with a reduced incidence of side effects. Trial of gradual antidepressant withdrawal should be attempted after 6 –12 months. |
Antipsychotics including atypicals
|
Risk of hypotension is dose related reduced by the ‘start low go slow approach.’ Atypical antipsychotics have similar falls risk to traditional ones. Attempted withdrawal MUST always be gradual. Prochlorperazine is often inappropriately prescribed for dizziness and causes drug induced Parkinson’s disease |
Anti-muscarinic drugs (Anticholinergics) |
Oxybutynin may cause acute confusional states in the elderly especially those with pre-existing cognitive impairment |
Benzodiazepines & Hypnotics
|
Dose reduction is beneficial if withdrawal is not possible . Avoid long acting benzodiazepines. Newer hypnotics are associated with reduced hangover effects but all licensed for short-term use only |
Dopaminergics used in Parkinson’s disease |
Sudden excessive daytime sleepiness can occur with levodopa and other dopamine receptor agonists. Dose titration is important in initiation due risk of inducing confusion. Maintenance doses may need to be reduced with aging |
Moderate risk |
|
Anti-arrhythmics |
Dizziness and drowsiness are possible signs of digoxin toxicity. Risks of toxicity are greater in renal impairment or in the presence of hypokalaemia. Flecainide has a high risk for drug interactions and can also cause dizziness |
Anti-epileptics |
High risk for potential drug interactions. Important side effects include: Dizziness, drowsiness and blurred vision (dose related) |
Opiate analgesics |
Drowsiness is common with initiation, but tolerance to this is usually seen within 2 weeks of continuous treatment. Drowsiness is rare with codeine unless used in combination with other CNS drugs. Confusion reported with tramadol |
Antihistamines |
Somnolence may affect up-to 40% of patients with older antihistamines. The newer antihistamines cause less sedation and psychomotor impairment. Risk of hypotension with cinnarizine is a dose related side effect |
Alpha-blockers |
Doses used for treatment of BPH less likely to cause hypotension than those required to treat hypertension |
ACEI/ARB |
Risk of hypotension is potentiated by concomitant diuretic use. Incidence of dizziness affects twice as many patients with heart failure than hypertension |
Diuretics |
Postural hypotension, dizziness and nocturia are problems seen in the elderly. Diuretics should not be used in the long-term treatment of gravitational oedema |
Beta-blockers
|
Postural hypotension and can affect up to 10% of patients. Can accumulate in renal impairment and therefore dose reduction is often necessary |
Lower risk |
|
CCBs |
Incidence of dizziness low especially for once daily dihydropyridine CCBs |
Nitrates |
Advise patient to sit when using GTN spray or tablets |
Oral anti-diabetic drugs |
Dizziness due to hypoglycaemia, but usually avoidable. Avoid long acting sulfonylureas e.g. chlorpropamide. |
PPIs & H2 Antagonists |
Avoid cimetidine in polypharmacy patients as high risk of drug interactions, and causes confusion. |